Ir al contenido principal

Enfermedad de Schamberg

Benign dermatoses with pupura

Profesionales Médicos

Los artículos de Referencia Profesional están diseñados para ser utilizados por profesionales de la salud. Están escritos por médicos del Reino Unido y se basan en evidencia de investigación, así como en guías del Reino Unido y Europa. Puede encontrar uno de nuestros artículos de salud más útil.

What is Schamberg's disease?

Synonyms: progressive pigmented purpuric dermatitis, Gougerot-Blum capillaritis, itching purpura, pigmented purpuric eruption1

Schamberg's disease is the most common type of the pigmented purpuric dermatoses (PPDs). It is chronic, benign, cutaneous eruptions characterised by petechiae, purpura and increased skin pigmentation (brown, red, or yellow patchy). The PPDs are grouped into:

  • Progressive pigmentary purpura or Schamberg's disease.

  • Pigmented purpuric lichenoid dermatitis of Gougerot and Blum - red/brown papules and plaques in men - which responds to psoralen combined with ultraviolet A (PUVA) treatment.

  • Purpura annularis telangiectodes - rare, with a preponderance in young females and manifesting as annular erythematous plaques and patches.

  • Eczematoid-like purpura of Doucas and Kapetanakis - occurring in men, with bilateral intensely itchy lesions on legs.

  • Lichen aureus - a localised persistent form of pigmented purpuric dermatitis.

  • Itching purpura of Lowenthal (disseminated pruriginous angiodermatitis) - rare (like Schamberg's disease) but accompanied by itching.

There is clinical and histological overlap between these and they may actually represent variable presentations of the same disease process.

Who is affected by Schamberg disease? (Epidemiology)

Schamberg's disease is rare and there are few epidemiological studies in the literature.

Schamberg disease may affect all ages but commonly occurs in middle-aged to older men and less frequently in children, although cases have been reported in children aged under two. 2

There has been a case report of four family members with Schamberg's disease, suggesting a possible genetic link.3

Schamberg's disease causes (aetiology) 4

The underlying cause is not known. However, the following have been postulated:

  • Recent viral infection.

  • Consumo de alcohol.

  • Hypersensitivity to an unknown causal agent.

  • Aberrant cell-mediated immunity (perivascular infiltrate has specific types of CD cells only).

  • Associated with certain medications - thiamine, aspirin, chlordiazepoxide and paracetamol. It has also been reported with bezafibrate and amlodipine.5

  • There is an association with hepatitis B, in which case treatment of the hepatitis may improve the skin.

Schamberg's disease symptoms4

There are no symptoms of Schamberg's disease apart from itching and patients noting their skin looks blotchy. For some this is enough to cause psychological distress. However, some patients have reported pains in their limbs - which may be coincidental.

Lesions are most commonly on the lower limbs bilaterally but can occur anywhere or be unilateral. A case involving the genitals has been reported.

The lesions consist of:

  • Asymmetrical brown/orange patches.

  • Non-blanchable purpura.

  • Petechiae called 'cayenne pepper spots' (develop at the edge of old lesions).

Patterns can vary - for example, annular, linear. There may also be associated lichenification, scaling and pruritic marks.

Diagnóstico diferencial16

Other causes of pigmented purpura include:

Investigaciones

  • Blood tests - including platelets and clotting - are usually normal.

  • Autoantibody screen and hepatitis serology should be performed.

  • Skin biopsy - histology reveals a capillaritis of dermal vessels. Other changes that may be seen include perivascular inflammatory infiltrate, endothelial hypertrophy with extravasation of blood cells and haemosiderin-laden macrophages.9

  • Examination of the skin, using a dermatoscope, may be helpful although there are limited reports in the literature.110

Enfermedades asociadas11 12

Schamberg's disease treatment and management1 4 11

Any suspected precipitants should be withdrawn.

  • Pruritis - treat with mild topical corticosteroid or antihistamines.

  • Good results have been obtained with narrow-band ultraviolet light.

  • Aminaphtone, a drug normally used in other venous conditions such as chronic venous congestion of the lower limbs can be used.13

  • Superimposed infection - will need antibiotics.

  • Systemic steroids provide some benefits but these are outweighed by the risks of systemic side-effects.

  • Advanced fluorescent technology using pulses of light has produced some promising cosmetic results.1415

Other tried treatments include vitamin C supplements, laser therapy and wearing support hosiery to prevent venous stasis. There is no evidence from randomised blinded trials of definite benefit of the former two, although case studies exist suggesting benefits from both. Immunosuppressants have also been used. PUVA treatment has been used successfully.2

Pronóstico

Schamberg's disease usually runs a chronic course with frequent exacerbations and remissions. The rash may be present for many years with slow extension. Pigmented purpura may occasionally disappear spontaneously.

Actualizaciones exclusivas para profesionales de la salud

Mantente informado con las últimas actualizaciones clínicas, perspectivas profesionales y orientación basada en evidencia. El boletín de Patient Pro selecciona contenido esencial para profesionales de la salud, entregado directamente en tu bandeja de entrada.

Por favor, introduce una dirección de correo electrónico válida

Al suscribirte aceptas nuestros Política de Privacidad. Puedes darte de baja en cualquier momento. Nunca vendemos tus datos.

Lecturas adicionales y referencias

  1. Zaldivar Fujigaki JL, Anjum F; Schamberg Disease. StatPearls, Jan 2026
  2. Spigariolo CB, Giacalone S, Nazzaro G; Pigmented Purpuric Dermatoses: A Complete Narrative Review. J Clin Med. 2021 May 25;10(11). pii: jcm10112283. doi: 10.3390/jcm10112283.
  3. Sethuraman G, Sugandhan S, Bansal A, et al; Familial pigmented purpuric dermatoses. J Dermatol. 2006 Sep;33(9):639-41.
  4. Capillaritis; DermNet NZ
  5. Schetz D, Kocic I; A new adverse drug reaction - Schamberg's disease caused by amlodipine administration - a case report. Br J Clin Pharmacol. 2015 Aug 10. doi: 10.1111/bcp.12742.
  6. Ho C, Yan P, Mistry N, et al; Dermacase: Can you identify this condition? 4. Progressive pigmented purpuric Can Fam Physician. 2010 Oct;56(10):1023, 1024-5.
  7. Ugajin T, Satoh T, Yokozeki H, et al; Mycosis fungoides presenting as pigmented purpuric eruption. Eur J Dermatol. 2005 Nov-Dec;15(6):489-91.
  8. Nikam BP, Singh NJ, Shetty DD; Primary benign hypergammaglobulinemic purpura of Waldenstrom masquerading as disseminated Schamberg's purpura. Indian J Dermatol Venereol Leprol. 2011 Mar-Apr;77(2):205-8.
  9. Billings S et al; Inflammatory Dermatopathology: A Pathologist's Survival Guide, 2010.
  10. Khopkar U; Dermoscopy and Trichoscopy in Diseases of the Brown Skin, 2013.
  11. Kim DH, Seo SH, Ahn HH, et al; Characteristics and Clinical Manifestations of Pigmented Purpuric Dermatosis. Ann Dermatol. 2015 Aug;27(4):404-10. doi: 10.5021/ad.2015.27.4.404. Epub 2015 Jul 29.
  12. Sardana K, Sarkar R, Sehgal VN; Pigmented purpuric dermatoses: an overview; Int J Dermatol. 2004 Jul;43(7):482-8.
  13. de Godoy JM, Batigalia F; Aminaphtone in the control of Schamberg's disease. Thromb J. 2009 Jun 11;7:8.
  14. Manolakos DA, Weiss J, Glick B, et al; Treatment of Schamberg's disease with advanced fluorescence technology. J Drugs Dermatol. 2012 Apr;11(4):528-9.
  15. Demidion DV, Olisova OY, Kostenko AY, et al; Complete clearance of Schamberg disease lesions with intense pulsed light. Photodermatol Photoimmunol Photomed. 2023 Jan;39(1):78-81. doi: 10.1111/phpp.12810. Epub 2022 Jun 14.
  16. Shen A et al; Capillaritis as a potential harbinger of cutaneous T-cell lymphoma, 2004

Sobre el autorVer biografía completa

Imagen del autor

Dra. Toni Hazell, MRCGP

MBBS, BSc, MRCGP, DFSRH, Dip GU med, DRCOG, DCH (London, UK, 2000)

La Dra. Toni Hazell se graduó de la Escuela de Medicina del Hospital St. Mary y realizó su VTS en el Hospital Northwick Park.

Acerca del revisorVer biografía completa

Imagen del autor

Dra. Philippa Vincent, MRCGP

Médico General, Autor Médico

MB BS, Bsc, MRCGP (2000), DCH, DFSRH, DRCOG

Dra Philippa Vincent es un médico de cabecera del NHS que trabaja en el norte de Londres.

Historial del artículo

La información en esta página está escrita y revisada por pares por clínicos calificados.

verificador de elegibilidad para la gripe

Pregunta, comparte, conecta.

Navega por discusiones, haz preguntas y comparte experiencias en cientos de temas de salud.

verificador de síntomas

¿Te sientes mal?

Evalúa tus síntomas en línea de forma gratuita